Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

NCT01604057 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Osteopenia

Interventions

DRUG: ZT-034 Low Dose Nasal Spray
DRUG: ZT-034 Mid Dose Nasal Spray
DRUG: ZT-034 High Dose Nasal Spray
DRUG: Teriparatide
DRUG: Placebo

Sponsor

Azelon Pharmaceuticals